Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.0K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.0K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

446
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
446
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

1.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

407
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
407
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

397
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
397
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.

Inflammatory bowel diseases·2024
Same author

Leucine-Rich Alpha-2 Glycoprotein May Be Predictive of the Adalimumab Trough Level and Antidrug Antibody Development for Patients with Inflammatory Bowel Disease: A Sub-Analysis of the PLANET Study.

Digestion·2021
Same author

Factors predicting major complications, mortality, and recovery in percutaneous endoscopic gastrostomy.

JGH open : an open access journal of gastroenterology and hepatology·2021
Same author

Linked color imaging versus white light imaging colonoscopy for colorectal adenoma detection: A randomized controlled trial.

Journal of gastroenterology and hepatology·2021
Same author

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Journal of gastroenterology·2021
Same author

Predictors of technical difficulty for complete closure of mucosal defects after duodenal endoscopic resection.

Gastrointestinal endoscopy·2021

Related Experiment Video

Updated: Jan 31, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K

Fecal microbiota transplantation.

Shinta Mizuno, Takanori Kanai

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |December 20, 2018
    PubMed
    Summary

    Fecal microbiota transplantation (FMT) shows potential for treating ulcerative colitis (UC) by restoring gut flora balance. Further research is needed to refine FMT methods for broader clinical application in gastrointestinal diseases.

    Area of Science:

    • Gastroenterology
    • Microbiology
    • Immunology

    Background:

    • The human gut harbors diverse microbial communities essential for health.
    • Dysbiosis, an imbalance in gut flora, is linked to various diseases, including inflammatory conditions.
    • Current therapeutic options for restoring gut symbiosis are limited.

    Purpose of the Study:

    • To explore the therapeutic potential of fecal microbiota transplantation (FMT) for ulcerative colitis (UC).
    • To address the ongoing debate regarding FMT efficacy in UC patients.
    • To highlight the need for advanced and convenient FMT methods.

    Main Methods:

    • Review of existing literature on fecal microbiota transplantation (FMT).
    • Analysis of FMT's proposed role in managing dysbiosis.

    More Related Videos

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
    05:41

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

    Published on: April 6, 2022

    3.5K
    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    27.7K

    Related Experiment Videos

    Last Updated: Jan 31, 2026

    Murine Fecal Isolation and Microbiota Transplantation
    07:32

    Murine Fecal Isolation and Microbiota Transplantation

    Published on: May 26, 2023

    5.6K
    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
    05:41

    Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

    Published on: April 6, 2022

    3.5K
    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    27.7K
  • Discussion of challenges and future directions in FMT research for UC.

    • Main Results:

    • Fecal microbiota transplantation (FMT) has demonstrated significant efficacy in treating recurrent Clostridium difficile infection.
    • FMT is proposed as a potential treatment strategy for ulcerative colitis (UC) to combat dysbiosis.
    • The effectiveness of FMT for UC remains under investigation and subject to debate.

    Conclusions:

    • Fecal microbiota transplantation (FMT) holds promise for managing ulcerative colitis (UC) by modulating the gut microbiome.
    • Further research is crucial to establish definitive efficacy and optimize FMT protocols for UC.
    • Development of more sophisticated and patient-friendly FMT methods is a key future challenge.